Event recordings

Replay our third episode of season 2 of the Risk of Living Longer series where we continued our theme of prevention by exploring the impact of behavioural change on longevity outcomes. Our speakers discussed how insurance companies and employers are encouraging change towards healthier behaviours.

Our second season of The Risk of Living Longer Series continued with the theme of prevention with a session focused on modelling gero-therapeutic interventions. We were joined by guest speakers from Crystallise Ltd who introduced their framework for understanding the impact of advances in gero-science. We addressed these key questions: what is gero-science and what are gero-therapeutics; how could we go about modelling the impact of gero-therapeutics; what is Crystallise’s framework for modelling the impact of advances in gero-science; how can practitioners use the outputs of this framework in practice.

President of the Geneva College of Longevity Science (GCLS), Dominik Thor welcomed esteemed colleagues and students from across 4 continents to the inaugural GCLS Semester Symposium in Geneva, Switzerland, where student and lecturer (and Club Vita Founder), Douglas Anderson presented "Longevity Economics: Impact on Insurance Industry".

After stellar engagement with our first series in Spring 2024, we are back by popular demand! It is our pleasure to announce the second season of our Risk of Living Longer webinars. Replay "Longevity science – advancing from cure to prevention" where we addressed these key questions: What is longevity science? Is prevention really better than a cure? What is preventative medicine (and why are we calling it medicine 3.0)? Should healthcare systems be spending more on prevention rather than cure? And how can this be encouraged? How can we encourage wider buy-in in society?

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Replay our last session of the series: Using Big Data and AI to Improve and Advance Longevity, to gain insights on the range of longevity-related AI use-cases: preventative medicine, accelerating drug discovery, establishing new genetic connections, and improving operational efficiency in health delivery. We also explored how the pace of change in longevity will be affected by AI developments, and which age groups are most likely to be affected.

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Watch session four of the series: Biological Clocks, to gain insights on how we can accelerate the feedback loop of medical interventions. We explored biomarkers: what they are, how accurate they are, and how they will develop. We also discussed implications from a life and health insurance perspective.

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Replay session three of the series: Cancer Research, to gain insights on the most exciting areas of cancer research, how close these areas could be to breakthrough, and how might such breakthroughs impact life insurance books.

Our "Risk of Living Longer" webinar series focuses on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Watch session two of the series: The biology of aging, to gain insights on how we should think in terms of the aging process, if we could ever cure aging, and what we could achieve along the way.

Our "Risk of Living Longer" webinar series focused on the impact of achieving significantly longer lifespans. How well is the risk of living longer really understood? Research has shown that people have a tendency to underestimate life expectancy, and actuaries have traditionally based future projections on historical trends. Watch session one of the series: An introduction to the question, gain insights on key areas of research to monitor for potential breakthroughs in longevity, what should we follow to understand the risk of living longer, and how could these considerations filter through into actuarial modeling and risk management.

Replay "What happened in 2022? The UK excess mortality conundrum, what caused it and will it continue?" where we explored 2022 as another unusual year for UK mortality. We again saw more deaths in the UK than expected under pre-pandemic projections, with these ‘excess deaths’ observed in the summer months and through to the end of the year. However, the number of deaths mentioning COVID-19 was relatively low. What is causing the excess deaths? Will the pattern continue? Is 2022 mortality data representative of future? Our panel of industry experts presented their views and findings on this subject, debated what’s causing these excess deaths, and shared their expectations for the future.

Replay "Looking to the horizon: how should we set long term longevity improvement rates?" where we explored the theory and practice of setting long term longevity improvements. We first gave an overview of methods available for actuaries in setting long term rates and then heard from our expert panel about considerations and methods that have been implemented in practice in Canada, the UK and the US.

Replay "Balancing privacy and best price in the age of US pension risk transfer" where our expert panel explored how useful it is for pension plans to share certain data fields, such as ZIP+4, with service providers. We discussed how reducing uncertainty by providing extra data fields could improve prices during a pension risk transfer. We examined techniques for anonymizing personal data while retaining the potential for predictive analytics. Our panel also shared their latest thinking on the newly released American Data Privacy Protection Act and gave insight into how other countries have dealt with similar challenges.

A new Club Vita survey, showing that people in Canada, the UK and US consistently underestimate their life expectancy, also shows that indicators of engagement are associated with better predictions of life expectancy.

Replay the third in our series of educational webinars; Longevity 103 where we discussed the management of longevity risk.

Replay our uplifting webinar where we discussed reasons to be cheerful: exploring potential big-ticket drivers of future longevity improvements.

This is a recording of our webinar where we will focus on how mortality rates are expected to change in the future. These changes are commonly known as improvements, as we usually expect life expectancy to increase over time. To allow for the possibility that life expectancy may not always increase, we also refer to these changes as trends.

This is a recording of our webinar, during which we took stock of the current situation of the ongoing pandemic, and looked at vaccine roll out and emerging strains. We explored how scenario modeling, a cornerstone of risk management, can be used to explore the longevity risk arising as a result of the pandemic, and presented scenario analysis completed by Club Vita, that is also available in the whitepaper accompanying this webinar.

This recorded webinar was the first in a series of Club Vita educational webinars on actuarial techniques for calculating longevity/mortality rates. In Longevity 101, we focused on the building blocks of longevity assumptions: current, or “baseline” longevity.

In new research we analysed Club Vita’s UK and Canadian data sets in search of evidence of a distinct public/private sector effect on longevity. This webinar recording presents the results of this analysis and examines a specific case study for the OPSEU Pension Plan, a large Canadian public sector pension plan.

Whilst the grim advance of the COVID-19 pandemic has continued since our webinar on April 15th, the likely changes to our future world have also started to come into focus.

The COVID-19 pandemic is one of the most serious health emergencies of modern times. In the replay of our second special webinar, our distinguished panel of experts will speak about the topics at hand and answer your questions.

The COVID-19 pandemic is one of the most serious health emergencies of modern times. In this webinar replay, our distinguished panel of experts will speak about the topics at hand and answer your questions. A detailed Q&A from the session is also posted with the recording.

In this webinar replay, we discuss communication and its effect on how people respond to issues of longevity, mortality, long-term planning and risk.

In this webinar replay, we discuss the recent longevity trends.

In this webinar replay, we'll discuss the basics about dementia, take a look at the outlook of current research and explore effects of future longevity.

Club Vita's 10th Birthday Seminar

In this webinar replay, Club Vita’s architect-in-chief, Steven Baxter will introduce the latest thinking on enabling index-based transfers of longevity and mortality risks.

Watch our webinar replay where a panel of leading experts discuss the current understanding of climate change and the potential implications for pension plans and insurance companies. This webinar covers what is happening now and what may happen in the future, how this will affect investments and pension scheme demographics and how the developing regulatory environment will affect those responsible for pension plan funding.

Peter Joshi, nurse-turned-medical-researcher, Nicola Oliver and Douglas Anderson, Founder of Club Vita discuss the big issues.